Celon Pharma S.A. (WSE:CLN)
Poland
· Delayed Price · Currency is PLN 22.30
+0.30 (1.36%)
Jun 27, 2025, 4:41 PM CET
Celon Pharma Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -43.86 | -34.45 | -28.12 | -39.28 | -11.61 | -0.92 | Upgrade
|
| Depreciation & Amortization | 51.54 | 51.15 | 48.95 | 42.43 | 39.38 | 29.59 | Upgrade
|
| Other Amortization | 0.86 | 0.71 | 1.06 | 1.67 | 1.96 | 2.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.61 | -7.64 | -10.95 | -3.48 | -0.13 | 0.32 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.59 | -9.74 | - | - | - | - | Upgrade
|
| Other Operating Activities | -1.47 | 0.16 | 11.86 | 2.56 | 0.28 | -2.95 | Upgrade
|
| Change in Accounts Receivable | -15.16 | -1.64 | -12.54 | -6.46 | 13.24 | 2.42 | Upgrade
|
| Change in Inventory | -1.29 | -3.77 | 11.98 | -15.01 | 6.38 | 0.3 | Upgrade
|
| Change in Other Net Operating Assets | 0.35 | -6.12 | -30.55 | 12.87 | -5.56 | 40.8 | Upgrade
|
| Operating Cash Flow | -17.23 | -11.34 | -8.31 | -4.7 | 43.95 | 71.74 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -38.73% | - | Upgrade
|
| Capital Expenditures | -25.92 | -22.79 | -32.81 | -33.91 | -41.35 | -99.48 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.78 | 0.68 | 1.24 | 0.59 | 0.17 | 0.63 | Upgrade
|
| Cash Acquisitions | -16.36 | -16.36 | - | - | - | - | Upgrade
|
| Investment in Securities | 50 | 40 | 9.5 | - | -79.87 | 45.44 | Upgrade
|
| Other Investing Activities | 0.03 | 0.06 | 0.43 | 1.85 | - | 0.14 | Upgrade
|
| Investing Cash Flow | -9.56 | -7.49 | -21.64 | -31.47 | -121.05 | -53.27 | Upgrade
|
| Short-Term Debt Issued | - | 1.53 | 12.75 | - | - | 12.84 | Upgrade
|
| Total Debt Issued | 4.69 | 1.53 | 12.75 | - | - | 12.84 | Upgrade
|
| Short-Term Debt Repaid | - | -12.75 | - | - | -12.84 | - | Upgrade
|
| Long-Term Debt Repaid | - | -9.69 | -26.13 | -12.43 | -4.8 | -4.4 | Upgrade
|
| Total Debt Repaid | -21.68 | -22.44 | -26.13 | -12.43 | -17.64 | -4.4 | Upgrade
|
| Net Debt Issued (Repaid) | -16.99 | -20.91 | -13.37 | -12.43 | -17.64 | 8.44 | Upgrade
|
| Issuance of Common Stock | 40.51 | 40.51 | 0 | 0 | 216 | - | Upgrade
|
| Common Dividends Paid | -4.09 | -4.09 | -4.6 | -14.8 | -3.15 | -3.6 | Upgrade
|
| Other Financing Activities | -2.02 | -2.19 | -2.62 | -1.5 | -14.3 | -0.59 | Upgrade
|
| Financing Cash Flow | 17.42 | 13.32 | -20.59 | -28.72 | 180.91 | 4.25 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | -9.37 | -5.51 | -50.54 | -64.89 | 103.82 | 22.72 | Upgrade
|
| Free Cash Flow | -43.15 | -34.13 | -41.13 | -38.61 | 2.6 | -27.74 | Upgrade
|
| Free Cash Flow Margin | -20.06% | -16.65% | -19.23% | -19.91% | 1.33% | -17.62% | Upgrade
|
| Free Cash Flow Per Share | -0.81 | -0.65 | -0.81 | -0.76 | 0.06 | -0.62 | Upgrade
|
| Cash Interest Paid | 2.02 | 2.19 | 2.62 | 1.5 | 0.94 | 0.59 | Upgrade
|
| Cash Income Tax Paid | - | -1.07 | -0.97 | -0.52 | - | -1.28 | Upgrade
|
| Levered Free Cash Flow | -34.56 | -23.92 | -34.98 | -18.83 | -1.33 | 4.24 | Upgrade
|
| Unlevered Free Cash Flow | -33.1 | -22.38 | -33.32 | -17.79 | -0.36 | 4.66 | Upgrade
|
| Change in Net Working Capital | 25.87 | 18.36 | 32.8 | 4.6 | -6.09 | -74.93 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.